Haja, Baby Boy .

HRN: 22-01-64  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/30/2022
AMPICILLIN 500MG (VIAL)
09/30/2022
10/07/2022
IV
150mg
Q12
Thickly MSAF
Waiting Final Action 
09/30/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
09/30/2022
10/07/2022
IV
15mg
Q24
Thickly MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: